Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE

Curr Hypertens Rep. 2005 Jun;7(3):155-7. doi: 10.1007/s11906-005-0001-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Clinical Trials as Topic
  • Diabetes Complications / drug therapy*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Antihypertensive Agents